Evidence map›Paper›PMID 32999931›Full record

ArticleACS central science2020

Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine-Cysteine Bond Formation.

Marco J Lobba, Christof Fellmann, Alan M Marmelstein, Johnathan C Maza, Elijah N Kissman, Stephanie A Robinson, Brett T Staahl, Cole Urnes, Rachel J Lew, Casey S Mogilevsky and 2 more

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Site-Selective Tyrosine Reaction for Antibody-Cell Conjugation and Targeted Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Marco J LobbaDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Christof FellmannDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720, United States.
Alan M MarmelsteinDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Johnathan C MazaDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Elijah N KissmanDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Stephanie A RobinsonDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Brett T StaahlDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720, United States.
Cole UrnesDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720, United States.
Rachel J LewGladstone Institutes, San Francisco, California 94158, United States.
Casey S MogilevskyDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Jennifer A DoudnaDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
Matthew B FrancisDepartment of Chemistry, University of California, Berkeley, California 94720, United States.
University of California, Berkeley · USGladstone Institutes · USLawrence Berkeley National Laboratory · US

Funding

Mechanism and Therapeutic Application of RNA-Guided Immune SystemsR00GM118909 · NIGMS · J. DAVID GLADSTONE INSTITUTES · PI FELLMANN, CHRISTOF · 2018 to 2020
$747k
Mechanism and therapeutic application of RNA-guided immune systemsK99GM118909 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI FELLMANN, CHRISTOF · 2016 to 2017
$180k
NIGMS NIH HHS K99 GM118909NIGMS NIH HHS R00 GM118909
6 · The paper itself

Abstract

The synthesis of protein-protein and protein-peptide conjugates is an important capability for producing vaccines, immunotherapeutics, and targeted delivery agents. Herein we show that the enzyme tyrosinase is capable of oxidizing exposed tyrosine residues into

Identifiers

PMID32999931
PMCPMC7517114
OpenAlexW3081110541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.